Cited by 312Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Alpha‐Synuclein as a Biomarker for Parkinson's Disease

Open access

Atik, Anzari, Stewart, Tessandra, Zhang, Jing·2016·Brain Pathology

DOI 10.1111/bpa.12370PMC PMC6245641

Open this paper in CoChat — free account

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder, characterized pathologically by the presence of α‐synuclein (α‐syn)‐rich Lewy bodies. As clinical diagnosis of PD is challenging, misdiagnosis is common, highlighting the need for disease‐specific and early stage biomarkers. Both early diagnosis of PD and adequate tracking of disease progression could significantly improve outcomes for patients, particularly in regard to existing and future disease modifying treatments. Given its critical roles in PD pathogenesis, α‐syn may be useful as a biomarker of PD. The aim of this review is, therefore, to summarize the efficacy of tissue and body fluid α‐syn measurements in the detection of PD as well as monitoring disease progression. In comparison to solid tissue specimens and biopsies, biofluid α‐syn levels may be the most promising candidates in PD diagnosis and progression based on specificity, sensitivity and availability. Although α‐syn has been tested most extensively in cerebrospinal fluid (CSF), the relatively invasive procedure for collecting CSF is not suitable in most clinical settings, leading to investigation of plasma, blood and saliva as alternatives. The exploration of combined biomarkers, along with α‐syn, to improve diagnostic accuracy is also likely required.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/bpa.12370

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,174
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Neuropathology of Parkinson's Disease
Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,304
Parkinson's disease. Second of two parts.
Lang, A., & Lozano, A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,193
Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,110
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Nalls, M. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 922
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal‐Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., & McLean, P. J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-42 · Cited by 880
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 824
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez‐Erviti, L., Seow, Y., Schapira, A. H. V., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. A. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 762
Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
Self-citation
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Mollenhauer, B., Locascio, J. J., Schulz‐Schaeffer, W., Sixel‐Döring, F., Trenkwalder, C., & Schlossmacher, M. G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70014-x · Cited by 636
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
Chen, L., & Feany, M. Β. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 634
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., et al. (2010) · Brain · doi:10.1093/brain/awq008 · Cited by 615
Self-citation
Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study
Rajput, A. H., Rozdilsky, B., & Rajput, A. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031814 · Cited by 594
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 593
The epidemiology of dementia associated with Parkinson disease
Aarsland, D., & Kurz, M. W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 572
Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
Barbour, R., Kling, K., Anderson, J. P., Banducci, K., Cole, T. A., Diep, L., Fox, M., Goldstein, J. M., Soriano, F., Seubert, P. A., et al. (2008) · Neurodegenerative Diseases · doi:10.1159/000112832 · Cited by 548
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
Tokuda, T., Qureshi, M. M., Ardah, M. T., Varghese, S., Shehab, S. A. S., Kasai, T., Ishigami, N., Tamaoka, A., Nakagawa, M., & El‐Agnaf, O. M. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd613b · Cited by 531
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 480
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
Li, W., West, N. C., Colla, E., Pletniková, O., Troncoso, J. C., Marsh, L., Dawson, T. M., Jäkälä, P., Hartmann, T., Price, D. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406976102 · Cited by 479
Biophysical Properties of the Synucleins and Their Propensities to Fibrillate
Uversky, V. N., Li, J., Souillac, P. O., Millett, I. S., Doniach, S., Jakes, R., Goedert, M., & Fink, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109541200 · Cited by 473
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Hall, S., Öhrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., Widner, H., Decraemer, H., Nägga, K., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1654 · Cited by 473
Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain · doi:10.1093/brain/awm302 · Cited by 469
Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms
Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease
Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G., & El-Agnaf, O. M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.024 · Cited by 425
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
Shi, M. Y., Bradner, J. M., Hancock, A. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22311 · Cited by 422
Self-citation
Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Fernández, C. O., Eliezer, D., Zweckstetter, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800747200 · Cited by 372
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Kang, J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3861 · Cited by 366
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D., Abbruzzese, G., & Tabaton, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01153-8 · Cited by 363
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
Miller, D. W., Hague, S., Clarimón, J., Baptista, M., Gwinn, K. A., Cookson, M., & Singleton, A. (2004) · Neurology · doi:10.1212/01.wnl.0000127517.33208.f4 · Cited by 356
Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein
Oueslati, A., Fournier, M., & Lashuel, H. A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83007-9 · Cited by 354
Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study
Aarsland, D., Perry, R., Brown, A. D., Larsen, J. O., & Ballard, C. G. (2005) · Annals of Neurology · doi:10.1002/ana.20635 · Cited by 347
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D. (2006) · Neurology · doi:10.1212/01.wnl.0000249130.63615.cc · Cited by 335
How valid is the clinical diagnosis of Parkinson's disease in the community?
Schrag, A. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.529 · Cited by 308
Phosphorylated α-Synuclein in Parkinson’s Disease
Wang, Y., Shi, M. Y., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., Srulijes, K., Trojanowski, J. Q., Lee, V. M. ‐., Siderowf, A. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002566 · Cited by 307
Self-citation
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
Tredici, K. D., Hawkes, C. H., Ghebremedhin, E., & Braak, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0665-2 · Cited by 303
Skin nerve α-synuclein deposits
Donadio, V. A., Incensi, A., Leta, V., Giannoccaro, M. P., Scaglione, C. L. M., Martinelli, P., Capellari, S., Avoni, P., Baruzzi, A., & Liguori, R. (2014) · Neurology · doi:10.1212/wnl.0000000000000316 · Cited by 301
Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies
Litvan, I., MacIntyre, A. T., Goetz, C. G., Wenning, G. K., Jellinger, K. A., Verny, M., Bartko, J. J., Jankovic, J. J., McKee, A. C., Brandel, J., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 299
Alpha-synuclein: from secretion to dysfunction and death
Marques, O., & Outeiro, T. F. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.94 · Cited by 296
Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins
Perrin, R. J., Woods, W. S., Clayton, D. F., & George, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105022200 · Cited by 283
Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases
Iwanaga, K., Wakabayashi, K., Yoshimoto, M., Tomita, I., Satoh, H., Takashima, H., Satoh, A., Seto, M., Tsujihata, M., & Takahashi, H. (1999) · Neurology · doi:10.1212/wnl.52.6.1269 · Cited by 277
-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells
Smith, W. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-05.2005 · Cited by 274
Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease
Parnetti, L., Chiasserini, D., Persichetti, E., Eusebi, P., Varghese, S., Qureshi, M. M., Dardis, A., Deganuto, M., Carlo, C. D., Castrioto, A., et al. (2014) · Movement Disorders · doi:10.1002/mds.25772 · Cited by 273
Diagnosis and the premotor phase of Parkinson disease
TOLOSA, E. S., Gaig, C., Santamaría, J., & Compta, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e318198db11 · Cited by 257
α-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 251
Calpain-Cleavage of α-Synuclein
Dufty, B. M., Warner, L., Hou, S., Jiang, S. X., Gómez‐Isla, T., Leenhouts, K. M., Oxford, J. T., Feany, M. Β., Masliah, E., & Rohn, T. T. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061232 · Cited by 245
The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
Lee, P. H., Lee, G., Park, H. J., Bang, O. Y., Joo, I. S., & Huh, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0427-9 · Cited by 242
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., Henry-Watson, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 237
Pathological lesions in colonic biopsies during Parkinson’s disease
Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Galmiche, J.-P., Varannes, S. B. D., Derkinderen, P., et al. (2008) · Gut · doi:10.1136/gut.2008.162503 · Cited by 237
Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232
Emerging Role of Neuronal Exosomes in the Central Nervous System
Chivet, M., Hemming, F. J., Pernet‐Gallay, K., Fraboulet, S., & Sadoul, R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00145 · Cited by 228
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Shi, M. Y., Zabetian, C. P., Hancock, A. M., Ginghină, C., Hong, Z., Yearout, D., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D. R., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.009 · Cited by 224
Self-citation
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
Devic, I., Hwang, H., Edgar, J. S., Izutsu, K. T., Presland, R. B., Pan, C., Goodlett, D. R., Wang, Y., Armaly, J., Tumas, V., et al. (2011) · Brain · doi:10.1093/brain/awr015 · Cited by 222
Self-citation
α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers
Beyer, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0104-6 · Cited by 216
Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Foulds, P. G., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P. J., Hasegawa, M., Taylor, M., Mann, D. M. A., & Allsop, D. (2011) · The FASEB Journal · doi:10.1096/fj.10-179192 · Cited by 210
Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
Öhrfelt, A., Grognet, P., Andreasen, N., Wallin, A., Vanmechelen, E., Blennow, K., & Zetterberg, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.015 · Cited by 201
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
Park, M., Cheon, S., Bae, H.-R., Kim, S.-H., & Kim, J. W. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.4.215 · Cited by 199
Phosphorylation Does Not Prompt, Nor Prevent, the Formation of -synuclein Toxic Species in a Rat Model of Parkinson's Disease
da Silveira, S. A., Schneider, B. L., Cifuentes-Díaz, C., Sage, D., Abbas‐Terki, T., Iwatsubo, T., Unser, M. A., & Aebischer, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn417 · Cited by 196
SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
Mata, I. F., Shi, M. Y., Agarwal, P., Chung, K. A., Edwards, K. L., Factor, S. A., Galasko, D. R., Ginghină, C., Griffith, A., Higgins, D. S., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.279 · Cited by 177
Self-citation
Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
Parnetti, L., Chiasserini, D., Bellomo, G., Giannandrea, D., Carlo, C. D., Qureshi, M. M., Ardah, M. T., Varghese, S., Bonanni, L., Borroni, B., et al. (2011) · Movement Disorders · doi:10.1002/mds.23670 · Cited by 173
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Yanamandra, K., Gruden, M. A., Casaite, V., Meskys, R., Forsgren, L., & Morozova-Roche, L. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018513 · Cited by 171
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Fujishiro, H., Frigerio, R., Burnett, M. S., Klos, K. J., Josephs, K. A., DelleDonne, A., Parisi, J. E., Ahlskog, J. E., & Dickson, D. W. (2008) · Movement Disorders · doi:10.1002/mds.21989 · Cited by 163
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Li, Q., Mok, S. S., Laughton, K. M., McLean, C., Cappai, R., Masters, C. L., Culvenor, J. G., & Horne, M. K. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.006 · Cited by 161
Biopsies of olfactory epithelium in patients with Parkinson's disease
Witt, M., Bormann, K., Gudziol, V., Pehlke, K., Barth, K., Minovi, A., Haehner, A., Reichmann, H., & Hummel, T. R. (2009) · Movement Disorders · doi:10.1002/mds.22464 · Cited by 154
Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx
Mu, L., Sobótka, S., Chen, J., Su, H., Sanders, I., Nyirenda, T. L., Adler, C. H., Shill, H. A., Caviness, J. N., Samanta, J., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182965886 · Cited by 153
Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease
Wang, X., Yu, S., Li, F., & Feng, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.030 · Cited by 151
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Mollenhauer, B., Trautmann, E., Taylor, P., Manninger, P., Sixel‐Döring, F., Ebentheuer, J., Trenkwalder, C., & Schlossmacher, M. G. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.004 · Cited by 143
The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease
Arawaka, S., Wada, M., Goto, S., Karube, H., Sakamoto, M., Ren, C.-H., Koyama, S., Nagasawa, H., Kimura, H., Kawanami, T., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0341-06.2006 · Cited by 142
Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration
Beyer, K., & Ariza, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8330-5 · Cited by 139
A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease
Pouclet, H., Lebouvier, T., Coron, E., Bruley des Varannes, S., Rouaud, T., Roy, M., Neunlist, M., & Derkinderen, P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.014 · Cited by 138
The Expression of α-, β-, and γ-Synucleins in Olfactory Mucosa from Patients with and without Neurodegenerative Diseases
Duda, J. E., Shah, U., Arnold, S. E., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7228 · Cited by 133
α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease
McFarland, N. R., Fan, Z., Xu, K., Schwarzschild, M. A., Feany, M. Β., Hyman, B. T., & McLean, P. J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a24b53 · Cited by 131
Expression of α-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineage
Nakai, M., Fujita, M., Waragai, M., Sugama, S., Wei, J., Akatsu, H., Ohtaka‐Maruyama, C., Okado, H., & Hashimoto, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.108 · Cited by 129
Excess burden of constipation in Parkinson's disease: a pilot study
Kaye, J., Gage, H., Kimber, A., Storey, L., & Trend, P. (2006) · Movement Disorders · doi:10.1002/mds.20942 · Cited by 128
α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals
Klos, K. J., Ahlskog, J. E., Josephs, K. A., Apaydın, H., Parisi, J. E., Boeve, B. F., DeLucia, M. W., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000204179.88955.fa · Cited by 127
Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease
Sato, H., Arawaka, S., Hara, S., Fukushima, S., Koga, K., Koyama, S., & Kato, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3967-11.2011 · Cited by 127
Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics
Sollinger, A. B., Goldstein, F. C., Lah, J. J., Levey, A. I., & Factor, S. A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.002 · Cited by 123
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Agbo, D. B., Wolf, E., Jessen, F., Oechsner, M., Hametner, E., Poewe, W. H., Reindl, M., Oertel, W. H., Noelker, C., Bacher, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b90d1 · Cited by 120
Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease
Beach, T. G., Adler, C. H., Dugger, B. N., Serrano, G. E., Hidalgo, J., Henry-Watson, J., Shill, H. A., Sue, L. I., Sabbagh, M. N., & Akiyama, H. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182805c72 · Cited by 117
Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
Durán, R., Barrero, F. J., Morales, B., Luna, J. D. D., Ramírez, M. R., & Vives, F. (2010) · Movement Disorders · doi:10.1002/mds.22928 · Cited by 114
Oxidative stress‐induced phosphorylation, degradation and aggregation of α‐synuclein are linked to upregulated CK2 and cathepsin D
Takahashi, M., Ko, L., Kulathingal, J., Jiang, P., Sevlever, D., & Yen, S.-H. C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05736.x · Cited by 113
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
Toledo, J. B., Korff, A., Shaw, L. M. J., Trojanowski, J. Q., & Zhang, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1148-z · Cited by 106
Self-citation
Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein
Levitan, K., Chéreau, D., Cohen, S. I. A., Knowles, T. P. J., Dobson, C. M., Fink, A. L., Anderson, J. P., Goldstein, J. M., & Millhauser, G. L. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.05.046 · Cited by 103
A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson’s disease
Pouclet, H., Lebouvier, T., Coron, E., Varannes, S. B. D., Neunlist, M., & Derkinderen, P. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01887.x · Cited by 102
Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization
Nakajo, S., Shioda, S., Nakai, Y., & Nakaya, K. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90187-2 · Cited by 100
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Stewart, T., Sossi, V., Aasly, J. O., Wszołek, Z. K., Uitti, R. J., Hasegawa, K., Yokoyama, T., Zabetian, C. P., Leverenz, J. B., Stoessl, A. J., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0185-3 · Cited by 100
Self-citation
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease
Michell, A. W., Luheshi, L. M., & Barker, R. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.02.030 · Cited by 92
Alpha‐synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients
Cersosimo, M. G., Perandones, C., Micheli, F. E., Raina, G. B., Beron, A. M., Nasswetter, G. G., Radrizzani, M., & Benarroch, E. E. (2010) · Movement Disorders · doi:10.1002/mds.23344 · Cited by 86
Saliva α-synuclein and a high extinction coefficient protein: A novel approach in assessment biomarkers of Parkinson′s disease
Al-Nimer, M. S. M., Mshatat, S., & Abdulla, H. I. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.147980 · Cited by 76
Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson’s disease: an anatomical study
Ghebremedhin, E., Tredici, K. D., Langston, J. W., & Braak, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0596-y · Cited by 74
α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
Smith, L. M., Schiess, M. C., Coffey, M. P., Klaver, A. C., & Loeffler, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052285 · Cited by 68
Biomarkers of Parkinson's disease: current status and future perspectives
Wang, J., Hoekstra, J. G., Zuo, C., Cook, T. J., & Zhang, J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.001 · Cited by 59
Self-citation
N‐terminal region of α‐synuclein is essential for the fatty acid‐induced oligomerization of the molecules
Karube, H., Sakamoto, M., Arawaka, S., Hara, S., Sato, H., Ren, C.-H., Goto, S., Koyama, S., Wada, M., Kawanami, T., et al. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.001 · Cited by 53
Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease
Elhadi, S. A., Honig, A., Simhi-Haham, D., Schechter, M., Linetsky, E., Ben‐Hur, T., & Sharon, R. (2015) · Scientific Reports · doi:10.1038/srep11120 · Cited by 51
α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
Gorostidi, A., Bergareche, A., Ruiz‐Martínez, J., Martí-Massó, J. F., Rodríguez-Oroz, M. C., Varghese, S., Qureshi, M. M., Alzahmi, F., Al‐Hayani, A., de Munaín, A. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052312 · Cited by 46
The native form of α-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls
Jakowec, M. W., Petzinger, G. M., Sastry, S., Donaldson, D. M., McCormack, A., & Langston, J. W. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00599-0 · Cited by 38
In Vitro Phosphorylation Does not Influence the Aggregation Kinetics of WT α-Synuclein in Contrast to Its Phosphorylation Mutants
Schreurs, S., Gérard, M., Derua, R., Waelkens, E., Taymans, J., Baekelandt, V., & Engelborghs, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011040 · Cited by 36
Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells
Wu, B., Liu, Q., Duan, C., Li, Y., Yu, S., Chan, P., Uéda, K., & Yang, H. (2009) · Acta Histochemica · doi:10.1016/j.acthis.2009.07.007 · Cited by 34
An alternatively spliced form of rodent α-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in α-synuclein aggregation
McLean, P. J., & Hyman, B. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00154-4 · Cited by 32
Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control
Stewart, T., Sui, Y.-T., Gonzalez‐Cuyar, L. F., Wong, D. T., Akin, D., Tumas, V., Aasly, J. O., Ashmore, E., Aro, P., Ginghină, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.008 · Cited by 31
Self-citation

Sorted by citations

T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
Jo, M., Lee, S., Jeon, Y., Kim, S., Kwon, Y., & Kim, H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00513-7 · Cited by 427
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D. P., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 384
Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art
Silva, A. B. R. L., de Oliveira, R. W. G., Diógenes, G. P., Aguiar, M. F. D. C., Sallem, C. C., Lima, M. P. P., Filho, L. B. D. A., de Medeiros, S. D. P., de Mendonça, L. L. P., Filho, P. C. D. S., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101834 · Cited by 252
Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
Concha‐Marambio, L., Pritzkow, S., Shahnawaz, M., Farris, C. M., & Soto, C. A. (2023) · Nature Protocols · doi:10.1038/s41596-022-00787-3 · Cited by 263

See all 312

Authors: Atik, A., Stewart, T., & Zhang, J.
Affiliations: University of Washington (US)
ORCID: Zhang, Jing
Venue: Brain Pathology
Publisher: Wiley
Published: 2016-04-25
Volume: 26
Issue: 3
Pages: 410-418
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/bpa.12370
PMC: PMC6245641
OpenAlex: W2289901196
Cited by: 311
References: 119
Citations by year: 2026: 25 · 2025: 42 · 2024: 36 · 2023: 42 · 2022: 36 · 2021: 42 · 2020: 40 · 2019: 15 · 2018: 13 · 2017: 12 · 2016: 7
FWCI: 2.17
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Brain Pathology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (NIH) (U01 NS082137, P30 ES007033-6364, R01 AG033398, R01 ES016873, R01 ES019277, R01 NS057567, and P50 NS062684-6221)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: alpha-synuclein, Parkinson's disease, biomarkers, Lewy bodies, early diagnosis, disease progression monitoring, cerebrospinal fluid, plasma, blood, saliva, combined biomarkers, neurodegeneration
MeSH terms: Humans, Parkinson Disease, Biomarkers, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alpha‐Synuclein as a Biomarker for Parkinson's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks